Skip to main content
Mark Routbort, MD, Pathology, Houston, TX

MarkJ.RoutbortMD

Pathology Houston, TX

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Routbort is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Routbort's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematopathology, 2003 - 2004
  • Duke University Hospital
    Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1999 - 2003
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1999
  • Duke University
    Duke UniversityPhD, Neurobiology, 1998
  • University of Chicago
    University of ChicagoB.A., Chemistry, 1991
  • University of Chicago
    University of ChicagoM.S., Biochemistry/Molecular Biology, 1991

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2004 - 2026
  • NC State Medical License
    NC State Medical License 1999 - 2005
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Clinical Informatics
  • American Board of Pathology Hematology

Awards, Honors, & Recognition

  • Best Scientific Session Project Pathology Informatics, Advancing Practice, Instruction and Innovation through Informatics Conference, 2003, 2006
  • Best Postgraduate Student Project Advancing Pathology Informatics, Imaging, and the Internet Conference, 2002
  • Ruth K. Broad Biomedical Research Fellowship 1997
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise Through Non-Overlapping Molecular-Genetic Alterations  
    Mark J Routbort, Diana Bell, Victor G Prieto, Michael T Tetzlaff, Anna Yemelyanova, Bita Esmaeli, Clinical Cancer Research
  • Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps  
    Bailey AM, Mao Y, Zeng J, Holla V, Johnson A, Brusco L, Chen K, Mendelsohn J, Routbort MJ, Mills GB, Meric-Bernstam F, Discov Med, 1/1/2014
  • Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencing  
    Portier BP, Kanagal-Shamanna R, Luthra R, Singh R, Routbort MJ, Handal B, Reddy N, Barkoh BA, Zuo Z, Medeiros LJ, Aldape K, Patel KP, Am J Clin Pathol, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • The Impact of PHF6 Mutations in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
    Mark Routbort, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Evolutionary Action (EA) Score of TP53 Mutations Defines Prognostic Subsets within TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Mark Routbort, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • The Art and Science of Next Generation Sequencing Data Interpretation: Value of Pattern Recognition and Statistical Analysis in Distinguishing True Mutations from Arti...
    S Roy Chowdhuri, M Routbort, R Singh, K Aldape, R Broaddus, A Lazar, LJ Medeiros, B Barkho, N Reddy, R Luthra, KP Patel, Modern Pathology, 1/1/2014
  • Join now to see all

Lectures

  • Building a Data Warehouse for Clinical Next Generation Sequencing Data 
    Boston, MA - 1/26/2014
  • LIS Interfaces: Basics, Implementation and Pitfalls 
    Pittsburgh, PA - 1/13/2014
  • Informatics Driven Molecular Pathology Workshop 
    Pittsburgh, PA - 1/13/2014
  • Join now to see all

Other

Authored Content

  • Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
  • Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020